Mainz Biomed Bv Stock Buy Hold or Sell Recommendation
| MYNZ Stock | USD 0.22 0.04 15.38% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Mainz Biomed BV is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Mainz Biomed BV given historical horizon and risk tolerance towards Mainz Biomed. When Macroaxis issues a 'buy' or 'sell' recommendation for Mainz Biomed BV, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Mainz Biomed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Mainz and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Mainz Biomed BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Mainz |
Execute Mainz Biomed Buy or Sell Advice
The Mainz recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Mainz Biomed BV. Macroaxis does not own or have any residual interests in Mainz Biomed BV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Mainz Biomed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Mainz Biomed Trading Alerts and Improvement Suggestions
| Mainz Biomed BV generated a negative expected return over the last 90 days | |
| Mainz Biomed BV has high historical volatility and very poor performance | |
| Mainz Biomed BV has some characteristics of a very speculative penny stock | |
| Mainz Biomed BV has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 895.48 K. Net Loss for the year was (26.3 M) with profit before overhead, payroll, taxes, and interest of 177.62 K. | |
| Mainz Biomed BV currently holds about 26.01 M in cash with (21.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Mainz Biomed BV has a frail financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Mainz Biomed Shares Down 5.7 percent Heres What Happened |
Mainz Biomed Returns Distribution Density
The distribution of Mainz Biomed's historical returns is an attempt to chart the uncertainty of Mainz Biomed's future price movements. The chart of the probability distribution of Mainz Biomed daily returns describes the distribution of returns around its average expected value. We use Mainz Biomed BV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Mainz Biomed returns is essential to provide solid investment advice for Mainz Biomed.
| Mean Return | -0.34 | Value At Risk | -10.71 | Potential Upside | 13.04 | Standard Deviation | 8.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Mainz Biomed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Mainz Biomed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Mainz Biomed or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Mainz Biomed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Mainz stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | -0.47 | |
σ | Overall volatility | 8.77 | |
Ir | Information ratio | -0.05 |
Mainz Biomed Volatility Alert
Mainz Biomed BV is displaying above-average volatility over the selected time horizon. Mainz Biomed BV is a potential penny stock. Although Mainz Biomed may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Mainz Biomed BV. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Mainz instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Mainz Biomed Fundamentals Vs Peers
Comparing Mainz Biomed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Mainz Biomed's direct or indirect competition across all of the common fundamentals between Mainz Biomed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Mainz Biomed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Mainz Biomed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Mainz Biomed to competition |
| Fundamentals | Mainz Biomed | Peer Average |
| Return On Equity | -43.34 | -0.31 |
| Return On Asset | -0.99 | -0.14 |
| Operating Margin | (18.83) % | (5.51) % |
| Current Valuation | 21.38 M | 16.62 B |
| Shares Outstanding | 64.04 M | 571.82 M |
| Shares Owned By Insiders | 5.52 % | 10.09 % |
| Shares Owned By Institutions | 0.24 % | 39.21 % |
| Number Of Shares Shorted | 3.57 M | 4.71 M |
| Price To Book | 1.72 X | 9.51 X |
| Price To Sales | 17.87 X | 11.42 X |
| Revenue | 895.48 K | 9.43 B |
| Gross Profit | 177.62 K | 27.38 B |
| EBITDA | (25.01 M) | 3.9 B |
| Net Income | (26.3 M) | 570.98 M |
| Cash And Equivalents | 26.01 M | 2.7 B |
| Cash Per Share | 1.80 X | 5.01 X |
| Total Debt | 7.42 M | 5.32 B |
| Debt To Equity | 0.10 % | 48.70 % |
| Current Ratio | 10.83 X | 2.16 X |
| Book Value Per Share | (0.16) X | 1.93 K |
| Cash Flow From Operations | (21.94 M) | 971.22 M |
| Short Ratio | 0.76 X | 4.00 X |
| Earnings Per Share | (1.11) X | 3.12 X |
| Target Price | 2.0 | |
| Number Of Employees | 65 | 18.84 K |
| Beta | 0.076 | -0.15 |
| Market Capitalization | 16.39 M | 19.03 B |
| Total Asset | 15.41 M | 29.47 B |
| Retained Earnings | (69.33 M) | 9.33 B |
| Working Capital | (257.15 K) | 1.48 B |
| Net Asset | 15.41 M |
Mainz Biomed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Mainz . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Mainz Biomed Buy or Sell Advice
When is the right time to buy or sell Mainz Biomed BV? Buying financial instruments such as Mainz Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Mainz Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Fund Thematic Idea Now
USD Crypto Fund
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.